Assistance Listing 93.885
Cell and Gene Therapy (CGT) Access Model
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Centers for Medicare and Medicaid Services
Assistance Listing 93.885, “Cell and Gene Therapy (CGT) Access Model,” is a federal program administered by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. It provides cooperative agreement assistance. GrantsJunction currently tracks 0 open, 0 forecasted and 0 closed opportunities under this listing. The agency reported $4M in obligations for fiscal year 2025.
Program objective
The Cell and Gene Therapy (CGT) Access Model aims to improve the lives of people with Medicaid living with rare and severe diseases by increasing access to potentially transformative treatments. It is a multi-year, voluntary model for states and manufacturers to test whether a CMS-led approach to developing and administering outcomes-based agreements (OBAs) for cell and gene therapies increases Medicaid beneficiaries’ access to innovative treatment, improves their health outcomes, and reduces health care costs and burden to state Medicaid programs. The initial focus of the model is on access to gene therapy treatments for people living with sickle cell disease, a genetic blood disorder. Manufacturers and state participants joined the model through a Request for Application (RFA) process. States begin participation between January 2025 and January 2026. The Notice of Funding Opportunity (NOFO) announced the opportunity to apply for Cooperative Agreement funding to support states’ participation in the CGT Access Model. Cooperative Agreement funding is intended to support state model implementation activities and to support states that take steps to improve equitable access to gene therapy and multi-disciplinary, comprehensive care in conjunction with the model test.
As published in the SAM.gov Assistance Listing.
Current opportunities under 93.885
No open or forecasted opportunities are currently posted under this listing. Programs often post notices on an annual cycle — see recently closed opportunities below for timing.
Eligible applicants (program level)
- U.S. State Government (including the District of Columbia)
- U.S. Territory (or Possession) Government (including freely-associated states)
- State
Eligible applicants are States, the District of Columbia, and any U.S. Territory participating in the Medicaid Drug Rebate Program (MDRP). Eligible applicants must: • Apply to the State Request for Applications (RFA) by no later than March 14, 2025 • Apply to the Notice of Funding Opportunity (NOFO) by no later than March 14, 2025 • Sign a State Agreement with CMS by no later than June 1, 2025
Intended beneficiaries: State and U.S. Territories.
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Reported obligations by fiscal year
Historical data · not a predictionRange and average of financial assistance (from the listing): CMS may award a maximum of $9.55 million in Cooperative Agreement award funding to each selected recipient over the course of up to 10.5 years. The Cooperative Agreement period of performance is anticipated to be July 1, 2025 to December 31, 2035.
Source: SAM.gov Assistance Listing 93.885. Hatched bars are agency estimates. These totals do not indicate approval rates.Who gets funded
Historical data · not a predictionGrant obligations by fiscal year
Source: USAspending.gov (grants and cooperative agreements, award types 02–05), refreshed weekly. Names and amounts are as reported by agencies and prime recipients. Past recipients show where money went — not who is eligible or how likely an application is to succeed.
Frequently asked questions
What is ALN 93.885?
93.885 is the Assistance Listing Number for “Cell and Gene Therapy (CGT) Access Model.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
Who can apply under ALN 93.885?
The SAM.gov listing names these applicant types: U.S. State Government (including the District of Columbia), U.S. Territory (or Possession) Government (including freely-associated states) and State. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
How much funding does 93.885 provide?
The agency reported $3,998,000 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.